Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amer Sports Inc (AS) vs BioNano Genomics Inc (BNGO) Price & Performance

Amer Sports IncTrade
BioNano Genomics IncTrade

Price performance (Past 24H)

Key statistics

Amer Sports Inc vs BioNano Genomics Inc — how do they compare? Amer Sports Inc trades at $33.87 (market cap $19.69B), while BioNano Genomics Inc trades at $1.18 (market cap $13.66M). The key difference: Amer Sports Inc is far larger — about 1441.4× BioNano Genomics Inc's market cap, and Amer Sports Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.

ASBNGO
Market Cap
$19.69B$13.66M
Sector
TechnologyHealth
52-Week High
$41.96$4.92
52-Week Low
$29.54$1.06
Enterprise Value
$20.01B$16.26M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amer Sports Inc

Amer Sports (AS) trades at $33.03, down 8.68% in the past 24 hours, with a bearish technical signal from moving averages. The company reported strong Q1 2026 earnings of $0.38 per share, beating estimates, and raised full-year guidance. Revenue grew 32% year-over-year to $1.95 billion, driven by Arc'teryx and Salomon. Valuation ratios include a P/E of 42.3 and P/S of 2.8. Net income margin stands at 6.5% for 2025.

The outlook is positive due to consistent earnings beats and raised guidance, but high valuation and technical bearishness pose risks. Analyst consensus is strongly bullish with a $58.67 price target, suggesting significant upside. Key risks include reliance on brand momentum and market volatility. Investors should weigh strong fundamentals against current technical weakness.

BioNano Genomics Inc

BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.

The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.

Returns comparison

Trailing returns across standard periods

About Amer Sports Inc

Amer Sports is a global group of iconic sports and outdoor brands, including Arc'teryx, Salomon, Wilson, and Atomic. It designs and manufactures high-quality equipment, apparel, and footwear for athletes worldwide.

Read more on AS

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Read more on BNGO